Nordic Studies on Alcohol and Drugs《北欧酒精与药物研究》 (官网投稿) 简介 期刊简称NORD STUD ALCOHOL DR 参考译名《北欧酒精与药物研究》 核心类别 SSCI(2024版), 目次收录(维普), 知网外文库,外文期刊, IF影响因子 自引率 主要研究方向SUBSTANCE ABUSE Nordic Studies on Alcohol and Drugs《北欧酒精与...
Nordic Studies On Alcohol And Drugs SCIE SSCI 国际简称:NORD STUD ALCOHOL DR 参考译名:北欧酒精与毒品研究主要研究方向:SUBSTANCE ABUSE 非预警期刊 审稿周期: 30 Weeks 《北欧酒精与毒品研究》(Nordic Studies On Alcohol And Drugs)是一本由SAGE Publishing出版的以SUBSTANCE ABUSE为研究特色的国际...
北欧酒精与毒品研究(Nordic Studies On Alcohol And Drugs)是一本由SAGE Publishing出版的一本SUBSTANCE ABUSE学术刊物,主要报道SUBSTANCE ABUSE相关领域研究成果与实践。本刊已入选、社会科学引文索引(SCIE)来源期刊,该刊创刊于1938年,出版周期6 issues/year。2021-2022年最新版WOS分区等级:Q3,2023年发布的影响因子为1.9...
Nordic Studies On Alcohol And DrugsSCIESSCI NORD STUD ALCOHOL DR ISSN:1455-0725 E-ISSN:1458-6126 投稿咨询学术服务 基本信息 BASIC INFORMATION 审稿时间:30 Weeks 出版周期:6 issues/year 出版国家或地区:United Kingdom 创刊:1938 影响因子:1.9
Nordic Studies on Alcohol and Drugs is a fully peer-reviewed, open access journal for social science research on alcohol and drugs, as well as other substances and behaviours, such as gambling, gaming, eating, and smoking. Join the conversation about this journal Quartiles 1999200020012002200320042...
Trends in alcohol consumption, harms and policy: Norway 1990–2010. Nordic Studies on Alcohol and Drugs, 27(5), 449–463.Nordic Studies on Alcohol and Drugs (2009): Thematic issue 3/2009Anderson, P. in B. Baumberg. 2006b. Stakeholders' views of alcohol policy. Nordic Studies on Alcohol ...
期刊全称 nordic studies on alcohol and drugs 期刊简称 Print ISSN 1455-0725 Online ISSN 1458-6126 期刊出版社 是否开放获取 Open Access,OA 是 官网地址 期刊所属领域 期刊简介 JCR分区索引信息2021年数据 是否是SCIE(SCI) 注:SCI已经完全被SCIE取代,参考:SCI被取代 ...
全名/缩写Nordic Studies on Alcohol and Drugs 期刊ISSN1455-0725 2023-2024影响因子1.900 最新自引率0.00% 期刊官方网站 是否OA开放访问 通讯方式 涉及的研究方向 出版国家或地区 出版年份0 年文章数37 中科院JCR分区大类:生物小类:SUBSTANCE ABUSE(药物滥用) 4区 ...
Alcohol-related liver disease (ALD) End-stage liver disease Immune-mediated liver diseases MASLD & MASH (formerly NAFLD & NASH) Viral liver diseases Enhanced Liver Fibrosis (ELF) Test Translational models in hepatic fibrosis Metabolic dysregulation ...
The FDA endorses the CPa9-HNE assay for further investigation as a tool for clinical trials, where it can support multiple objectives, such as clinical trial enrichment, assessing the pharmacodynamic effects of immunomodulatory drugs, and monitoring treatment response. For instance, CPa9-HNE strongly...